documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
608,707 rows where document_type = "Supporting & Related Material" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_date (date), last_modified (date)
These facets timed out: agency_id, posted_year
document_type 1
- Supporting & Related Material · 608,707 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPA-R01-SFUND-2026-0826-0014 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | REDACTED 2020 ANNUAL REPORT - OPERABLE UNIT (OU) 1 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:32Z | 0 | 0 | 09000064b92d874b | ||||
| EPA-R01-SFUND-2026-0826-0006 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | FINAL 2025 ANNUAL REPORT | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:31Z | 0 | 0 | 09000064b92d8739 | ||||
| EPA-HQ-OPPT-2018-0465-0072 | EPA | trans-1,2- Dichloroethylene; TSCA Review EPA-HQ-OPPT-2018-0465 | September 10, 2024 Amended Final Report TDCE Abiotic Feasibility Study submitted by BCCM | Supporting & Related Material | Report | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-16T01:40:23Z | 0 | 0 | 09000064b92d9dcf | |||
| EPA-R01-SFUND-2026-0826-0003 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | FINAL TECHNICAL MEMORANDUM PROPOSED ALTERNATIVE REMEDY | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:30Z | 0 | 0 | 09000064b92d8736 | ||||
| EPA-R01-SFUND-2026-0826-0010 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | ROOT CAUSE ANALYSIS AND MONITORIING NETWORK EVALUATION INSTALLATION OF DEEP BEDROCK MONITORING WELLS | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:32Z | 0 | 0 | 09000064b92d873d | ||||
| EPA-R01-SFUND-2026-0826-0008 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | DRAFT FINAL FOCUSED FEASIBILITY STUDY (FS) REPORT | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:31Z | 0 | 0 | 09000064b92d873b | ||||
| EPA-R01-SFUND-2026-0826-0007 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | SAVAGE MUNICIPAL WATER SUPPLY OPERABLE UNIT (OU) 1 DRAFT THIRD EXPLANATION OF SIGNIFICANT DIFFERENCES (ESD) FOR P | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:31Z | 0 | 0 | 09000064b92d873a | ||||
| EPA-R01-SFUND-2026-0826-0011 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | THIRD FIVE-YEAR REVIEW REPORT | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:32Z | 0 | 0 | 09000064b92d8748 | ||||
| EPA-R01-SFUND-2026-0826-0004 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | FINAL FOCUSED FEASIBILITY STUDY (FFS) REPORT | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:30Z | 0 | 0 | 09000064b92d8737 | ||||
| EPA-R01-SFUND-2026-0826-0012 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | REDACTED REMEDIAL INVESTIGATION (RI) REPORT ADDENDUM FOR TECHNICAL IMPRACTICABILITY (TI) ZONE BEDROCK | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:32Z | 0 | 0 | 09000064b92d8749 | ||||
| EPA-R01-SFUND-2026-0826-0002 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | FINAL PERMEABLE REACTIVE BARRIER CONCEPTUAL DESIGN REPORT | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:30Z | 0 | 0 | 09000064b92d8735 | ||||
| EPA-R01-SFUND-2026-0826-0015 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | REDACTED FINAL 2010 ANNUAL REPORT - OPERABLE UNIT (OU) 1 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:32Z | 0 | 0 | 09000064b92d874c | ||||
| EPA-R01-SFUND-2026-0826-0013 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | REDACTED FINAL 2024 ANNUAL REPORT | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:32Z | 0 | 0 | 09000064b92d874a | ||||
| EPA-R01-SFUND-2026-0826-0009 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | ANNUAL REPORT FOR 2008 (03172010 TRANSMITTAL LETTER ATTACHED) | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:31Z | 0 | 0 | 09000064b92d873c | ||||
| EPA-R01-SFUND-2026-0826-0005 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | FINAL PRE-REMEDIAL DESIGN INVESTIGATION REPORT | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T17:14:31Z | 0 | 0 | 09000064b92d8738 | ||||
| FWS-HQ-IA-2026-0298-0003 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: George Sammut, Morgan Hill, CA; Permit No. PER26821388 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:00Z | 0 | 0 | 09000064b92d957b | ||||
| FWS-HQ-IA-2026-0298-0009 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: St. Augustine Alligator Farm, St. Augustine, FL; Permit No. PER21244411 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:02Z | 0 | 0 | 09000064b92d9581 | ||||
| FWS-HQ-IA-2026-0298-0011 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: St. Augustine Alligator Farm, St. Augustine, FL; Permit No. PER21244412 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:02Z | 0 | 0 | 09000064b92d95a1 | ||||
| FWS-HQ-IA-2026-0298-0005 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: Craig Keller, Tunkhannock, PA; Permit No. PER25338256 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:01Z | 0 | 0 | 09000064b92d957d | ||||
| FWS-HQ-IA-2026-0298-0002 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: Stephen Isenhour, Hickory, NC; Permit No. PER26245661 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:00Z | 0 | 0 | 09000064b92d957a | ||||
| FWS-HQ-IA-2026-0298-0010 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: Collin Griffiths, Missoula, MT; Permit No. PER26935891 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:02Z | 0 | 0 | 09000064b92d95a0 | ||||
| FWS-HQ-IA-2026-0298-0007 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: Brandon Isenhour, Hickory, NC; Permit No. PER26245660 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:01Z | 0 | 0 | 09000064b92d957f | ||||
| FWS-HQ-IA-2026-0298-0013 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: Henry Vilas Zoo, Madison, WI; Permit No. PER27541931 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:03Z | 0 | 0 | 09000064b92d95a3 | ||||
| FWS-R5-FAC-2026-1684-0004 | FWS | Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs FWS-R5-FAC-2026-1684 | FWS Form 3-2493 American Shad Recapture Data draft Rev 07-2017 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:48:12Z | 0 | 0 | 09000064b92d9025 | ||||
| FWS-HQ-IA-2026-0298-0004 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: Charlie Dally, Rathdrum, ID; Permit No. PER27974123 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:00Z | 0 | 0 | 09000064b92d957c | ||||
| FWS-HQ-IA-2026-0298-0006 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: Sam Noble Oklahoma Museum of Natural History, Norman, OK; Permit No. PER25540581 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:01Z | 0 | 0 | 09000064b92d957e | ||||
| FWS-HQ-IA-2026-0298-0008 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: Vicki Lynn Lee, Ft. Collins, CO; Permit No. PER26618348 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:02Z | 0 | 0 | 09000064b92d9580 | ||||
| FWS-HQ-IA-2026-0298-0012 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: Turtle Conservancy, Ojai, CA; Permit No. PER27229456 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:03Z | 0 | 0 | 09000064b92d95a2 | ||||
| FWS-R5-FAC-2026-1684-0005 | FWS | Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs FWS-R5-FAC-2026-1684 | FWS Form 3-2310 Horseshoe Crab Recapture Report Rev 07-2017 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:48:14Z | 0 | 0 | 09000064b92d9026 | ||||
| FWS-R5-FAC-2026-1684-0007 | FWS | Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs FWS-R5-FAC-2026-1684 | FWS Form 3-2311 Horseshoe Crab Tagging Report Rev 07-2017 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:48:16Z | 0 | 0 | 09000064b92d9035 | ||||
| FWS-R5-FAC-2026-1684-0003 | FWS | Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs FWS-R5-FAC-2026-1684 | FWS Form 3-2496 Sturgeon Recapture Data Rev 07-2017 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:48:11Z | 0 | 0 | 09000064b92d9024 | ||||
| FWS-R5-FAC-2026-1684-0002 | FWS | Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs FWS-R5-FAC-2026-1684 | FWS Form 3-2495 Striped Bass Recapture Data Rev 07-2017 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:48:09Z | 0 | 0 | 09000064b92d9023 | ||||
| FWS-HQ-IA-2026-0298-0016 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: John Ball Zoo, Grand Rapids, MN; Permit No. PER27754098 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:04Z | 0 | 0 | 09000064b92d95a6 | ||||
| FWS-HQ-IA-2026-0298-0015 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: Turtle Survival Alliance, North Charleston, SC; Permit No. PER27332264 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:03Z | 0 | 0 | 09000064b92d95a5 | ||||
| FWS-R5-FAC-2026-1684-0006 | FWS | Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs FWS-R5-FAC-2026-1684 | FWS Form 3-2494 Snakehead Recapture Data Rev 07-2017 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:48:15Z | 0 | 0 | 09000064b92d9027 | ||||
| FWS-HQ-IA-2026-0298-0014 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Applicant: Minnesota Zoo, Apple Valley, MN; Permit No. PER26188753 | Supporting & Related Material | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:54:03Z | 0 | 0 | 09000064b92d95a4 | ||||
| EPA-R05-OAR-2025-3654-0014 | EPA | Cleveland, Ohio 2015 8-Hour Ozone Redesignation and Maintenance Plan EPA-R05-OAR-2025-3654 | On-road Testing Contract for Enhanced Inspection and Maintenance (I/M) Programs under Ohio's Ozone Attainment Demonstration for the Cleveland, OH 2015 Serious Ozone Nonattainment Area | Supporting & Related Material | State/Tribal Submittal | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T18:51:31Z | 0 | 0 | 09000064b92d86c4 | |||
| EPA-R09-OAR-2026-2608-0006 | EPA | Determination of Attainment by the Attainment Date and Clean Data Determination for the 2012 Annual Fine Particulate Standard; Plumas County, California EPA-R09-OAR-2026-2608 | NPRM Docket Index_Portola CDD DAAD | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T21:20:32Z | 0 | 0 | 09000064b92d8fa4 | ||||
| EPA-R10-RCRA-2026-2146-0003 | EPA | Alaska: Final Authorization of State Hazardous Waste Management Program EPA-R10-RCRA-2026-2146 | AK.Statutes.and.Regulations_FRL.13305-01-R10_NPRM | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T20:17:11Z | 0 | 0 | 09000064b92d1f51 | ||||
| EPA-R05-OAR-2025-3654-0013 | EPA | Cleveland, Ohio 2015 8-Hour Ozone Redesignation and Maintenance Plan EPA-R05-OAR-2025-3654 | Cleveland Attainment Demonstration SIGNED_DATED -R5 transmittal letter | Supporting & Related Material | State/Tribal Submittal | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T18:51:29Z | 0 | 0 | 09000064b92d868f | |||
| EPA-R09-OAR-2026-2608-0003 | EPA | Determination of Attainment by the Attainment Date and Clean Data Determination for the 2012 Annual Fine Particulate Standard; Plumas County, California EPA-R09-OAR-2026-2608 | B. State Plans, Support Documents, Reports, and Correspondence | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T21:20:25Z | 0 | 0 | 09000064b92d8f66 | ||||
| EPA-HQ-OPP-2025-0177-0010 | EPA | Application for Section 3 Registration of Three new Active Ingredients Containing Spinach Defensin Proteins for use in Citrus EPA-HQ-OPP-2025-0177 | Product label: Construct CTV-SoD2-1 | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T16:39:23Z | 0 | 0 | 09000064b92cf35b | ||||
| EPA-HQ-OPP-2025-0177-0007 | EPA | Application for Section 3 Registration of Three new Active Ingredients Containing Spinach Defensin Proteins for use in Citrus EPA-HQ-OPP-2025-0177 | Product Characterization and Human Health Risk Assessment for Citrus tristeza virus (CTV) strain T36 expressing Spinach Defensin Proteins (SoD) 2, 2-1, and 2* (March 26, 2026) | Supporting & Related Material | Data | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T16:39:22Z | 0 | 0 | 09000064b92cf32b | |||
| EPA-HQ-OPP-2025-0177-0012 | EPA | Application for Section 3 Registration of Three new Active Ingredients Containing Spinach Defensin Proteins for use in Citrus EPA-HQ-OPP-2025-0177 | Proposed Registration Decision for the New Microbial Pesticide Active Ingredients: Citrus tristeza virus (CTV) strain T36 expressing Spinach Defensin Protein SoD2, Citrus tristeza virus (CTV) strain T36 expressing Spinach Defensin Protein SoD2-1, and Citrus tristeza virus (CTV) strain T36 expressing Spinach Defensin Protein SoD2* | Supporting & Related Material | Decision | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T16:39:23Z | 0 | 0 | 09000064b92d0205 | |||
| EPA-R10-OAR-2026-0694-0003 | EPA | Approval and Promulgation of Delegation of Authority for Designated Facilities and Pollutants; Washington; Northwest Clean Air Agency EPA-R10-OAR-2026-0694 | 002_5-26-17 Opinion Letter-attachments condensed | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:13:33Z | 0 | 0 | 09000064b9187ea4 | ||||
| EPA-R10-RCRA-2026-2146-0006 | EPA | Alaska: Final Authorization of State Hazardous Waste Management Program EPA-R10-RCRA-2026-2146 | AK.State Public Comment Process_FRL.13305-01-R10_NPRM | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T20:17:19Z | 0 | 0 | 09000064b92d1f24 | ||||
| EPA-R10-RCRA-2026-2146-0007 | EPA | Alaska: Final Authorization of State Hazardous Waste Management Program EPA-R10-RCRA-2026-2146 | AK.Governor Transmittal 02.24.2026_FRL13305-01-R10_NPRM | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T20:17:23Z | 0 | 0 | 09000064b92d1f23 | ||||
| EPA-R10-RCRA-2026-2146-0002 | EPA | Alaska: Final Authorization of State Hazardous Waste Management Program EPA-R10-RCRA-2026-2146 | AK.Program Description_FRL.13305-01-R10_NPRM | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T20:17:08Z | 0 | 0 | 09000064b92d1f52 | ||||
| EPA-R10-OAR-2026-0694-0004 | EPA | Approval and Promulgation of Delegation of Authority for Designated Facilities and Pollutants; Washington; Northwest Clean Air Agency EPA-R10-OAR-2026-0694 | 001_NWCAA SSI Request for Delegation | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:13:41Z | 0 | 0 | 09000064b9187ea3 | ||||
| EPA-R10-OAR-2026-0694-0005 | EPA | Approval and Promulgation of Delegation of Authority for Designated Facilities and Pollutants; Washington; Northwest Clean Air Agency EPA-R10-OAR-2026-0694 | 003_TSD NWCAA SSI plan | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:13:48Z | 0 | 0 | 09000064b9187ea2 | ||||
| EPA-R10-RCRA-2026-2146-0005 | EPA | Alaska: Final Authorization of State Hazardous Waste Management Program EPA-R10-RCRA-2026-2146 | AK_Attorney.Generals.Statement_FRL13305-01-R10_NPRM | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T20:17:16Z | 0 | 0 | 09000064b92d1f4f | ||||
| EPA-HQ-OPP-2025-0177-0009 | EPA | Application for Section 3 Registration of Three new Active Ingredients Containing Spinach Defensin Proteins for use in Citrus EPA-HQ-OPP-2025-0177 | Product label: Construct CTV-SoD2 | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T16:39:23Z | 0 | 0 | 09000064b92cf35a | ||||
| EPA-HQ-OPP-2025-0177-0011 | EPA | Application for Section 3 Registration of Three new Active Ingredients Containing Spinach Defensin Proteins for use in Citrus EPA-HQ-OPP-2025-0177 | Product label: Construct CTV-SoD2* | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T16:39:23Z | 0 | 0 | 09000064b92cf3be | ||||
| EPA-R09-OAR-2026-2608-0004 | EPA | Determination of Attainment by the Attainment Date and Clean Data Determination for the 2012 Annual Fine Particulate Standard; Plumas County, California EPA-R09-OAR-2026-2608 | C. Additional Documents for Proposed Rulemaking | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T21:20:28Z | 0 | 0 | 09000064b92d8f80 | ||||
| EPA-R09-OAR-2026-2608-0002 | EPA | Determination of Attainment by the Attainment Date and Clean Data Determination for the 2012 Annual Fine Particulate Standard; Plumas County, California EPA-R09-OAR-2026-2608 | A. U.S. EPA Guidance Documents, Policies, and Rulemakings | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T21:20:23Z | 0 | 0 | 09000064b92d7394 | ||||
| EPA-HQ-OPPT-2025-3358-0007 | EPA | Science Advisory Committee on Chemicals (SACC); Request for Nominations of Ad hoc Peer Reviewers EPA-HQ-OPPT-2025-3358 | Biographies of interested and available candidates under consideration for selection as ad hoc peer reviewers for the SACC peer review of selected TSCA-designated High-Priority chemicals undergoing risk evaluation in Mid-2026 | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-15T02:14:29Z | 0 | 0 | 09000064b92d9d74 | ||||
| EPA-HQ-OPP-2025-0177-0008 | EPA | Application for Section 3 Registration of Three new Active Ingredients Containing Spinach Defensin Proteins for use in Citrus EPA-HQ-OPP-2025-0177 | Environmental Risk Assessment for the New Active Ingredients Spinach Defensin Protein 2 (GE CTV-SoD2, CTV-SoD2-1, and CTV-SoD2*) as Expressed in Genetically Engineered Citrus Tristeza Virus Strain T36 Isolates. Data and Information Were Provided in Support of Applications for FIFRA Section 3 End Use Registrations | Supporting & Related Material | Risk Assessment | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T16:39:23Z | 0 | 0 | 09000064b92cf33b | |||
| EPA-R10-OAR-2026-0694-0002 | EPA | Approval and Promulgation of Delegation of Authority for Designated Facilities and Pollutants; Washington; Northwest Clean Air Agency EPA-R10-OAR-2026-0694 | 004_MoA_NWCAA_p62_LLL_2018 | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T16:52:25Z | 0 | 0 | 09000064b9187ea1 | ||||
| EPA-R10-RCRA-2026-2146-0001 | EPA | Alaska: Final Authorization of State Hazardous Waste Management Program EPA-R10-RCRA-2026-2146 | Notice of Completeness Determination for Alaska RCRA Subtitle C Program Authorization | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T20:17:03Z | 0 | 0 | 09000064b92d46e9 | ||||
| EPA-R10-RCRA-2026-2146-0004 | EPA | Alaska: Final Authorization of State Hazardous Waste Management Program EPA-R10-RCRA-2026-2146 | AK.EPA_Memorandum_Agreement_FRL.13305-01-R10_NPRM | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T20:17:13Z | 0 | 0 | 09000064b92d1f50 | ||||
| EPA-R09-OAR-2026-2608-0005 | EPA | Determination of Attainment by the Attainment Date and Clean Data Determination for the 2012 Annual Fine Particulate Standard; Plumas County, California EPA-R09-OAR-2026-2608 | D. Notice of Proposed Rulemaking | Supporting & Related Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T21:20:30Z | 0 | 0 | 09000064b92d8f9a | ||||
| EPA-HQ-SFUND-2015-0100-0035 | EPA | Continuous Release Reporting Regulations (CRRR) under CERCLA 1980; Continuous Release Reporting Requirement Including Analysis for Use of Continuous Release Reporting Forms (Renewal) EPA-HQ-SFUND-2015-0100 | Supporting Statement 2050-0086 1445.16 2022 508 | Supporting & Related Material | ICR Supporting Statement | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T21:17:55Z | 0 | 0 | 09000064b92d3d9d | |||
| FDA-2026-P-5454-0009 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | References 7 - Smarr, M. M., et al. (2016). Urinary paracetamol and time-to-pregnancy. Human Reproduction, 31(9), 2119-2127. URL: https://pubmed.ncbi.nlm.nih.gov/27412248/ | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:42:39Z | 0 | 0 | 09000064b92d5011 | |||
| FDA-2026-P-5454-0014 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 12 - de Araújo-Ramos, A. T., et al. (2026). Differential disruption of gonadal development by DEHP and paracetamol in male and female Wistar rats. Reproductive Toxicology, 141, 109183. URL: https://doi.org/10.1016/j.reprotox.2026.109183 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:42:56Z | 0 | 0 | 09000064b92d5031 | |||
| FDA-2026-P-5454-0015 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 13 - Laursen, T. Q., et al. (2024). Maternal intake of paracetamol during pregnancy and biomarkers of male fecundity in young adult sons. Reproductive Toxicology, 127, 108626. URL: https://doi.org/10.1016/j.reprotox.2024.108626 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:43:00Z | 0 | 0 | 09000064b92d5032 | |||
| FDA-2026-P-5454-0011 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 9 - Carlsen, L. N., et al. (2024). Overuse of analgesics can affect the fertility biomarker Anti-Müllerian Hormone in females. A translational study. Cephalalgia, 44(11). URL: https://doi.org/10.1177/03331024241290530 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:42:46Z | 0 | 0 | 09000064b92d5013 | |||
| FDA-2026-P-5454-0004 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | References 2 - Fisher, B. G., et al. (2016). Prenatal paracetamol exposure is associated with shorter anogenital distance in male infants. Human Reproduction, 31(11), 2642-2650. URL: https://pubmed.ncbi.nlm.nih.gov/27609981/ | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:41:58Z | 0 | 0 | 09000064b92d500c | |||
| FDA-2026-P-5454-0013 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 11 - Wu, T., et al. (2024). Prenatal acetaminophen exposure and the developing ovary: time, dose, and course consequences for fetal mice. Food and Chemical Toxicology, 189, 114679. URL: https://doi.org/10.1016/j.fct.2024.114679 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:42:53Z | 0 | 0 | 09000064b92d5030 | |||
| FDA-2026-P-5578-0004 | FDA | Requests that the FDA declare that an ANDA may be submitted for, Tranexamic Acid Tablets, USP 1300 mg a strength that differs from the currently approved RLD, LYSTEDA (Tranexamic Acid) tablets from AMRING PHARMACEUTICALS INC., which FDA approved in 650 mg strength prior to Nov, 13th 2009 under NDA #022430. FDA-2026-P-5578 | Attachment 2 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T23:18:09Z | 0 | 0 | 09000064b92d70f1 | |||
| FDA-2026-P-5578-0005 | FDA | Requests that the FDA declare that an ANDA may be submitted for, Tranexamic Acid Tablets, USP 1300 mg a strength that differs from the currently approved RLD, LYSTEDA (Tranexamic Acid) tablets from AMRING PHARMACEUTICALS INC., which FDA approved in 650 mg strength prior to Nov, 13th 2009 under NDA #022430. FDA-2026-P-5578 | Attachment 3 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T23:18:14Z | 0 | 0 | 09000064b92d70f2 | |||
| FDA-2026-P-5454-0017 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 15 - Lee, C. Y., et al. (2023). Effects of acetaminophen on reproductive activities in male golden hamsters. Development & Reproduction, 27(1), 25-37. URL: https://doi.org/10.12717/DR.2023.27.1.25 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:43:26Z | 0 | 0 | 09000064b92d5034 | |||
| FDA-2026-P-5611-0003 | FDA | Request that the FDA determine and declare that Gabapentin Tablets 150 mg is suitable for submission in an Abbreviated New Drug Application (ANDA) FDA-2026-P-5611 | attachment-1-orange-book-page | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T23:37:59Z | 0 | 0 | 09000064b92d874f | |||
| FDA-2026-P-5454-0021 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 19 - Eletri, L., et al. (2026). Association between in utero exposure to acetaminophen and external genital tract malformations in boys and girls: a systematic review and meta-analysis. Human Reproduction, 41(3), 427-442. URL: https://doi.org/10.1093/humrep/deaf253 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:43:53Z | 0 | 0 | 09000064b92d5038 | |||
| FDA-2026-P-5454-0003 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | References 1 - Ernstsen, C., et al. (2026). Prenatal paracetamol modulates sexually dimorphic behaviour and steroidogenesis in adult male and female mice. Reproduction, 171(2). URL: https://doi.org/10.1093/reprod/xaag007 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:41:54Z | 0 | 0 | 09000064b92d500b | |||
| FDA-2026-P-5454-0006 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | References 4 - Guzmán-Montemayor, A. J., et al. (2026). Prenatal, but not neonatal, paracetamol exposure disrupts neuroendocrine regulation of stress and emotional behavior in adult male rats. Physiology & Behavior, 308, 115261. URL: https://doi.org/10.1016/j.physbeh.2026.115261 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:42:16Z | 0 | 0 | 09000064b92d500e | |||
| FDA-2026-P-5454-0007 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | References 5 - Górawski, F., et al. (2026). Sex-dependent effects of early-life paracetamol exposure on behavior and monoamines in the rat central nervous system. Chemico-Biological Interactions, 427, 111937. URL: https://doi.org/10.1016/j.cbi.2026.111937 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:42:31Z | 0 | 0 | 09000064b92d500f | |||
| FDA-2026-P-5611-0004 | FDA | Request that the FDA determine and declare that Gabapentin Tablets 150 mg is suitable for submission in an Abbreviated New Drug Application (ANDA) FDA-2026-P-5611 | attachment-2-rld-labeling | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T23:38:03Z | 0 | 0 | 09000064b92d8750 | |||
| FDA-2026-P-5611-0005 | FDA | Request that the FDA determine and declare that Gabapentin Tablets 150 mg is suitable for submission in an Abbreviated New Drug Application (ANDA) FDA-2026-P-5611 | attachment-3-test-product-draft-labeling | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T23:38:07Z | 0 | 0 | 09000064b92d8751 | |||
| FDA-2026-P-5454-0005 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 3 - Lind, D. V., et al. (2017). Maternal use of mild analgesics during pregnancy associated with reduced anogenital distance in sons. Human Reproduction, 32(1), 149-155. URL: https://pubmed.ncbi.nlm.nih.gov/27852690/ | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:42:12Z | 0 | 0 | 09000064b92d500d | |||
| FDA-2026-P-5454-0018 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 16 - Xu, M., et al. (2024). Association of acetaminophen use with perinatal outcomes among pregnant women: a retrospective cohort study with propensity score matching. BMC Pregnancy and Childbirth, 24, 268. URL: https://doi.org/10.1186/s12884-024-06480-5 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:43:29Z | 0 | 0 | 09000064b92d5035 | |||
| FDA-2026-P-5454-0023 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 21 - OFIRMEV (acetaminophen) Injection Package Insert. (2018). Mallinckrodt Hospital Products Inc. | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:44:02Z | 0 | 0 | 09000064b92d503a | |||
| FDA-2026-P-5454-0020 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 18 - Rehfeld, A., et al. (2022). Human sperm cells can form paracetamol metabolite AM404 that directly interferes with sperm calcium signalling and function through a CatSper-dependent mechanism. Human Reproduction, 37(5), 922-935. URL: https://doi.org/10.1093/humrep/deac042 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:43:48Z | 0 | 0 | 09000064b92d5037 | |||
| FDA-2026-P-5454-0022 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 20 - Kougias, D. G., et al. (2025). A quantitative weight-of-evidence review of preclinical studies examining the potential developmental and reproductive toxicity of acetaminophen. Critical Reviews in Toxicology, 55(2), 179-226. URL: https://doi.org/10.1080/10408444.2024.2446471 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:43:58Z | 0 | 0 | 09000064b92d5039 | |||
| FDA-2026-P-5454-0010 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | References 8 - Nielsen, B. S., et al. (2025). Paracetamol disrupts early embryogenesis by cell cycle inhibition. Human Reproduction, 40(10), 1860-1876. URL: https://doi.org/10.1093/humrep/deaf116 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:42:42Z | 0 | 0 | 09000064b92d5012 | |||
| FDA-2026-P-5454-0019 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 17 - Zafeiri, A., et al. (2022). Maternal over-the-counter analgesics use during pregnancy and adverse perinatal outcomes: cohort study of 151,141 singleton pregnancies. BMJ Open, 12(5), e048092. URL: https://doi.org/10.1136/bmjopen-2020-048092 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:43:32Z | 0 | 0 | 09000064b92d5036 | |||
| FDA-2026-P-5454-0008 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | References 6 - Lecante, L. L., et al. (2022). Acetaminophen interferes with the first trimester human fetal ovary development in an ex vivo model. Journal of Clinical Endocrinology & Metabolism, 107(6), 1647-1661. URL: https://pubmed.ncbi.nlm.nih.gov/35147701/ | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:42:35Z | 0 | 0 | 09000064b92d5010 | |||
| FDA-2026-P-5454-0012 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 10 - Liu, F., et al. (2024). Maternal administration of acetaminophen affects meiosis through its metabolite NAPQI targeting SIRT7 in fetal oocytes. Antioxidants & Redox Signaling, 41, 93-109. URL: https://doi.org/10.1089/ars.2023.0270 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:42:50Z | 0 | 0 | 09000064b92d502f | |||
| FDA-2026-P-5454-0016 | FDA | Request that the FDA take action to amend OTC acetaminophen labeling regarding reproductive toxicity, fertility impairment, and developmental endocrine disruption FDA-2026-P-5454 | Reference 14 - Andreasen, S. M., et al. (2025). Maternal urinary paracetamol concentrations and self-reported paracetamol use in mid-gestation: association to reduced anogenital distance in offspring from infancy to 9 years. Reproductive Toxicology, 135, 108946. URL: https://pubmed.ncbi.nlm.nih.gov/40374128/ | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T17:43:22Z | 0 | 0 | 09000064b92d5033 | |||
| FDA-2026-P-5578-0003 | FDA | Requests that the FDA declare that an ANDA may be submitted for, Tranexamic Acid Tablets, USP 1300 mg a strength that differs from the currently approved RLD, LYSTEDA (Tranexamic Acid) tablets from AMRING PHARMACEUTICALS INC., which FDA approved in 650 mg strength prior to Nov, 13th 2009 under NDA #022430. FDA-2026-P-5578 | Attachment 1 | Supporting & Related Material | Background Material | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T23:18:06Z | 0 | 0 | 09000064b92d70f0 | |||
| EPA-HQ-OAR-2025-0618-0023 | EPA | Revision to “Begin Actual Construction” in the New Source Review Preconstruction Permitting Program EPA-HQ-OAR-2025-0618 | Letter from E. Stuart, Steel Manufacturers Association to EPA | Supporting & Related Material | Letter | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T16:54:07Z | 0 | 0 | 09000064b92c3ba9 | |||
| EPA-HQ-OAR-2025-0618-0013 | EPA | Revision to “Begin Actual Construction” in the New Source Review Preconstruction Permitting Program EPA-HQ-OAR-2025-0618 | Letter from B. Stout, BP America, Inc. to Department of Commerce | Supporting & Related Material | Letter | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T16:54:05Z | 0 | 0 | 09000064b92c4a21 | |||
| EPA-HQ-OPPT-2018-0458-0073 | EPA | Phosphoric acid, triphenyl ester (TPP); TSCA Review EPA-HQ-OPPT-2018-0458 | TPP Dermal OECD428 ACC Final Study Report EPA Response 15 July 25 | Supporting & Related Material | Letter | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T18:35:52Z | 0 | 0 | 09000064b92c7f74 | |||
| EPA-HQ-OAR-2025-0618-0017 | EPA | Revision to “Begin Actual Construction” in the New Source Review Preconstruction Permitting Program EPA-HQ-OAR-2025-0618 | Letter from C. Fitzsimmons, Iowa Department of Natural Resources (DNR) to EPA | Supporting & Related Material | Letter | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T16:54:05Z | 0 | 0 | 09000064b92c1c28 | |||
| EPA-HQ-OAR-2025-0618-0020 | EPA | Revision to “Begin Actual Construction” in the New Source Review Preconstruction Permitting Program EPA-HQ-OAR-2025-0618 | Letter from The National Environmental Development Association’s Clean Air Project (NEDACAP) to Department of Commerce | Supporting & Related Material | Letter | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T16:54:06Z | 0 | 0 | 09000064b92c3b43 | |||
| EPA-HQ-OAR-2025-0618-0007 | EPA | Revision to “Begin Actual Construction” in the New Source Review Preconstruction Permitting Program EPA-HQ-OAR-2025-0618 | Memorandum from J. Rasnic, EPA/OAQPS, to B. Turlinski, EPA Region III. Construction Activities at Georgia Pacific | Supporting & Related Material | Memorandum | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T16:54:03Z | 0 | 0 | 09000064b92c49b7 | |||
| EPA-HQ-OAR-2025-0618-0009 | EPA | Revision to “Begin Actual Construction” in the New Source Review Preconstruction Permitting Program EPA-HQ-OAR-2025-0618 | Memorandum from A. Idsal, EPA Principal Deputy Assistant Administrator, to Regional Air Division Directors. Interpretation of “Begin Actual Construction” Under the New Source Review Preconstruction Permitting Regulations. March 2020, Draft Memo | Supporting & Related Material | Memorandum | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T16:54:04Z | 0 | 0 | 09000064b92c49d0 | |||
| EPA-HQ-OAR-2025-0618-0010 | EPA | Revision to “Begin Actual Construction” in the New Source Review Preconstruction Permitting Program EPA-HQ-OAR-2025-0618 | Comments of the American Chemistry Council, American Forest & Paper Association, American Fuel & Petrochemical Manufacturers, American Petroleum Institute, American Wood Council, National Oilseed Processors Association, Portland Cement Association, Air Permitting Forum, and Auto Industry Forum on Draft Guidance on Interpretation of “Begin Actual Construction” | Supporting & Related Material | Letter | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T16:54:04Z | 0 | 0 | 09000064b92c49fa | |||
| EPA-HQ-OPPT-2018-0462-0080 | EPA | 4,4'-(1-Methylethylidene)bis[2, 6-dibromophenol] (TBBPA); TSCA Review EPA-HQ-OPPT-2018-0462 | TBBPA Consumer Exposure Protocol 6 and 9 ACC Final Study Report EPA Response 10 March 26 | Supporting & Related Material | Letter | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T18:36:50Z | 0 | 0 | 09000064b92c837d | |||
| EPA-HQ-OAR-2025-0618-0015 | EPA | Revision to “Begin Actual Construction” in the New Source Review Preconstruction Permitting Program EPA-HQ-OAR-2025-0618 | Letter from R. Singhal, Flexible Packaging Association to EPA | Supporting & Related Material | Letter | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T16:54:05Z | 0 | 0 | 09000064b92c4a33 | |||
| EPA-HQ-OAR-2025-0618-0005 | EPA | Revision to “Begin Actual Construction” in the New Source Review Preconstruction Permitting Program EPA-HQ-OAR-2025-0618 | Letter from J. Seitz, EPA/OAQPS to C. Williams, Minnesota Pollution Control Agency | Supporting & Related Material | Letter | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T16:54:03Z | 0 | 0 | 09000064b92c4295 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;